 |
Alan Phillip Cohen | |
|---|---|
| Born | October 5, 1954 |
| Education | University of Florida |
| Occupation | Business executive |
| Known for | Majority owner of the Florida Panthers, Founder/CEO of Andrx Pharmaceuticals Inc. |
| Spouse | Karen Cohen |
Alan Phillip Cohen (born October 5, 1954) is an American businessman, best known for his ownership of the Florida Panthers hockey team and his founding of several generic pharmaceutical companies, most notably the Davie, Florida-based Andrx Corp. Cohen.
In 1984, he founded the drug distribution firm Best Generics Inc. [1] and sold it to Florida's Ivax Corporation in 1988 for $10 million although he stayed on as President until 1990. In 1992, he founded Andrx Pharmaceuticals Inc., which he led as CEO to its inclusion in the Nasdaq100 in 1999. In 1996, the company went public at $12 and its stock eventually soared as high as $400 a share split adjusted. In October 2000, he left the company to purchase the Florida Panthers. In 2002, he created Abrika Pharmaceuticals Inc. [2] in Sunrise, Florida. Four years later, he sold it for $235 million to Actavis Group, an international generic drug company in Iceland.
He was the majority owner of the NHL's Florida Panthers from 2001 to 2009. [3]
Since 2003, he has been racing and breeding horses on his Arindel Farm in Ocala, Florida. One of his horses, Wait A While, competed in a Breeder's Cup race at Churchill Downs in 2006. She went on to become United States Champion 3 year old filly in 2006.
He and his wife, Karen, [4] live in Weston, Florida. [5] He is of Jewish descent. [1]
Harry Wayne Huizenga Sr. was an American businessman. He founded AutoNation and Waste Management Inc., and was the owner or co-owner of Blockbuster Video, the Miami Dolphins of the National Football League (NFL), the Florida Panthers of the National Hockey League (NHL), and the Miami Marlins of Major League Baseball (MLB).
Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.
Warner Chilcott was a company in the pharmaceutical industry based in Rockaway, New Jersey. It was primarily focused on women's healthcare and dermatology. On October 1, 2013, the company was acquired by Actavis.
Barr Pharmaceuticals was a global specialty and generic drug manufacturer with operations in 30 countries.
Bausch Health Companies Inc. is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products. Bausch Health's business model is primarily focused on acquiring small pharmaceutical companies and then sharply increasing the prices of the drugs these companies sell.
Eugene Nestor Melnyk was a Canadian businessman, philanthropist, and owner, governor, and chairman of the National Hockey League (NHL)'s Ottawa Senators and the American Hockey League's Belleville Senators. He was the founder, chairman, and CEO of Biovail Corporation, once Canada's largest publicly traded pharmaceutical company with more than CA$1 billion in annual revenue. He had sold almost all of his holdings in the company by 2010. Canadian Business magazine ranked Melnyk 79th on its 2017 list of Canada's 100 wealthiest people, with a net worth of CA$1.21 billion. He was one of the richest residents of Barbados.
Forest Laboratories was a company in the pharmaceutical industry incorporated in Delaware, with its principal office in New York City. It was known for licensing European pharmaceuticals for sale in the United States. On July 1, 2014, the company was acquired by Actavis.
Allergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics. Allergan, Inc. was formed in 1948, incorporated in 1950 and became a public company in 1970. It ceased operation in 2015 when it was acquired by Irish-based Actavis plc, who then renamed the group as Allergan plc.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Actavis Generics is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.
John Franks was an American businessman and a Thoroughbred racehorse owner and breeder. A native of Haughton, Louisiana, he earned a degree in geology from Louisiana State University. In 1957, he founded the highly successful Franks Petroleum Inc. and later invested in real estate with Franks Realty LLC. In 1989 he sold his petroleum company to Sonat Inc.
Michael Maroone is an American businessman. He served as President and Chief Operating Officer of AutoNation, Inc. from August 1999 until his retirement in February 2015. He also served as a Director of the Company from July 2005.
Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. It is a producer of generic therapeutic drugs and engaged in contract clinical research and manufacturing. It has 22 manufacturing plants, 17 in India and the rest in Greece, United Kingdom and Mexico. In the financial year 2019, 69% of the company's revenue came from international markets while 31% came from India. Its market presence is in more than 100+ countries.
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74, and rank 89 on the 2024 list. The company's primary product is Humira (adalimumab), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis.
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.
FTC v. Actavis, Inc., 570 U.S. 136 (2013), was a United States Supreme Court decision in which the Court held that the FTC could make an antitrust challenge under the rule of reason against a so-called pay-for-delay agreement, also referred to as a reverse payment patent settlement. Such an agreement is one in which a drug patentee pays another company, ordinarily a generic drug manufacturer, to stay out of the market, thus avoiding generic competition and a challenge to patent validity. The FTC sought to establish a rule that such agreements were presumptively illegal, but the Court ruled only that the FTC could bring a case under more general antitrust principles permitting a defendant to assert justifications for its actions under the rule of reason.
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox.
Alvogen is an Icelandic pharmaceutical company founded in 2009. In 2014, a controlling stake in the company was acquired by CVC Capital Partners and Temasek Holdings. Alvogen has about 350 different medical and non-medical products, and both produces its own products and markets the products of brand name pharmaceutical companies.
Wilhelm Róbert Wessman is an Icelandic business executive and founder of the pharmaceutical and biotechnology companies Alvotech and Alvogen.